Showing results (491-500 of 567) with videos related to

Sort By:
Pageof 57
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 27, 2020
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selectionPeter C Black, Nimira S Alimohamed, David Berman, et al.
Future Oncology (London, England)|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinomaMatthew D Galsky, Alexandra Drakaki, Arnab Basu, et al.
European Urology|May 17, 2023
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk FactorsIbrahim Jubber, Sean Ong, Laura Bukavina, et al.
Mucosal Immunology|September 20, 2012
Double-stranded RNA induces molecular and inflammatory signatures that are directly relevant to COPDP Harris, S Sridhar, R Peng, et al.
Cancer|October 4, 2019
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108Peter H O'Donnell, Hendrick Tobias Arkenau, Srikala S Sridhar, et al.
Plos One|December 1, 2021
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory studyEsmail M Al-Ezzi, Zachary W Veitch, Samer H Salah, et al.
Oncology and Therapy|April 17, 2025
On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBCBernadett E Szabados, Félix Guerrero-Ramos, Enrique Grande, et al.
Clinical Genitourinary Cancer|October 8, 2018
Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder CancerAndrea Necchi, Gregory R Pond, Marco Moschini, et al.
Breast Cancer Research and Treatment|November 28, 2017
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancerRossanna C Pezo, Tom W Chen, Hal K Berman, et al.
Physiological Reports|April 10, 2025
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failureYuliya Lytvyn, Rosalie A Scholtes, Eva M Boorsma, et al.
Pageof 57